A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Clinical trial NCT07115745 · RECRUITING
Trial details
- NCT number
- NCT07115745
- Sponsor
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-04
- Primary completion
- 2029-03-15
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.